Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA OKs Molecular Diagnostics' Pap collector:

This article was originally published in Clinica

Executive Summary

Molecular Diagnostics has received US FDA 510(k) clearance to market its InPath e2 Collector, a cervical sampling device that can collect cells for Pap test analysis in a single step. The device consists of a silicone balloon that is shaped like the cervix. When inflated, cells adhere to the balloon's surface, reducing trauma to the cervix that can occur using traditional Pap test collection methods that require scraping cells from two parts of the cervix in separate steps, says the Chicago, Illinois firm.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT066793

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel